Optimisation of renin-angiotensin-aldosterone system inhibitors use in chronic kidney disease patients with heart failure: is hyperkalaemia a barrier?
Event:
Heart Failure 2025
Topic:
Pharmacotherapy
Session:
Congestion, SGLT2 inhibitors and novel therapies
